Author

S. Roy-Chowdhuri

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

A. Adel Fouad Abdelhakeem· 1 shared A. J. Lazar· 1 shared A. Khanna· 1 shared A. P. Futreal· 1 shared B. Badgwell· 1 shared E. B. Roarty· 1 shared F. Sloulidis· 1 shared G. A. Calin· 1 shared

Activity by Year

2019-2019 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Adel Fouad Abdelhakeem

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell-of-Origin Analysis of Metastatic Gastric Cancer Uncovers the Origin of Inherent Intratumor Heterogeneity and a Fundamental Prognostic Signature

R. Wang, S. Song, K. Harada, G. Han, M. P. Pizzi, M. Zhao, G. Tatlonghari, S. Zhang, Y. Wang, S. Zhao, B. Badgwell, M. B. Murphy, N. Shanbhag, J. Estrella, S. Roy-Chowdhuri, , L. Wang

This study uses single-cell RNA sequencing to analyze the origin of intra-tumoral heterogeneity in gastric cancer and identifies a prognostic gene signature.

bioRxiv · Aug 5, 2019 · PreprintCancer Biology

Simplified Molecular Classification of Lung Adenocarcinomas Based on EGFR, KRAS, and TP53 Mutations

R. Ruiz-Cordero, J. Ma, A. Khanna, G. Lyons, W. Rinsurongkawong, R. Bassett, M. Guo, M. J. Routbort, J. Zhang, F. Sloulidis, J. V. Heymach, E. B. Roarty, Z. Tang, L. J. Medeiros, K. P. Patel, , S. Roy-Chowdhuri

This paper classifies lung adenocarcinomas into six subtypes based on EGFR, KRAS, and TP53 mutations, finding associations with prognosis and validating the classification against clinical outcomes.

bioRxiv · Jan 21, 2019Cancer Biology